JAKARTA - PT Kimia Farma Diagnostika, an integrated health services provider, announced the signing of a strategic cooperation agreement with PT Pfizer Indonesia. This collaboration aims to strengthen the national vaccination program as part of efforts to improve the health status of the Indonesian people.
Through this collaboration, both companies are committed to jointly educating the public about the importance of pneumonia vaccination as a long-term health investment, both from a clinical and economic perspective.
Pneumonia is still one of the main causes of death and hospitalization in Indonesia, both in infants and adults. This disease is also recorded as the number one cause of hospitalization in the hajj and umrah pilgrims, given the high density, physical exhaustion, and exposure to the environment during the performance of the worship.
Although the pneumonia vaccine is not included in the required vaccines, pneumonia vaccination can be considered as an additional vaccine to help protect pilgrims from the risk of infection, so that people can perform the hajj and umrah more safely and return to their home country in a healthy and protected condition.
With the main goal of increasing access and quality of health services, this cooperation reflects the commitment of both companies to make a real contribution to the health of the nation. In addition, this collaboration also supports the transformation of a more modern, science-based, and sustainable health service.
PT Kimia Farma Diagnostika is committed to playing an active role in disease prevention and improving the quality of life of the community through structured and measurable health programs.
Arie Genipa Suhendi, as President Director of PT Kimia Farma Diagnostika, said that this cooperation is a strategic step in realizing our commitment to not only provide integrated health services, but also play an active role in disease prevention and improving the quality of life of the Indonesian people.
"With this collaboration, we believe we can strengthen the national vaccination program and make a real contribution to the health of the nation," he said in a written statement, Saturday, February 14.
The scientific seminar held as part of this activity aims to strengthen the understanding of health workers, stakeholders, and the public about the benefits of vaccination in improving the quality of life and economic productivity. PT Kimia Farma Diagnostika and PT Pfizer Indonesia hope that this cooperation can have a sustainable positive impact on the Indonesian people, as well as strengthen the alignment of vision in creating a better and more affordable health service system.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
